Advanced search

An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting

(2004) JOURNAL OF HUMAN HYPERTENSION. 18(10). p.733-738
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
PALMER, AJ, Lieven Annemans, S ROZE, M LAMOTTE, RA RODBY, and RW BILOUS. 2004. “An Economic Evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK Setting.” Journal of Human Hypertension 18 (10): 733–738.
APA
PALMER, AJ, Annemans, L., ROZE, S., LAMOTTE, M., RODBY, R., & BILOUS, R. (2004). An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting. JOURNAL OF HUMAN HYPERTENSION, 18(10), 733–738.
Vancouver
1.
PALMER A, Annemans L, ROZE S, LAMOTTE M, RODBY R, BILOUS R. An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting. JOURNAL OF HUMAN HYPERTENSION. NATURE PUBLISHING GROUP; 2004;18(10):733–8.
MLA
PALMER, AJ, Lieven Annemans, S ROZE, et al. “An Economic Evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK Setting.” JOURNAL OF HUMAN HYPERTENSION 18.10 (2004): 733–738. Print.
@article{306032,
  author       = {PALMER, AJ and Annemans, Lieven and ROZE, S and LAMOTTE, M and RODBY, RA and BILOUS, RW},
  issn         = {0950-9240},
  journal      = {JOURNAL OF HUMAN HYPERTENSION},
  language     = {eng},
  number       = {10},
  pages        = {733--738},
  publisher    = {NATURE PUBLISHING GROUP},
  title        = {An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting},
  volume       = {18},
  year         = {2004},
}

Web of Science
Times cited: